{
  "description": "Table 7 appears to be the main results table as it summarizes the terminated clinical trials targeting CD47, including key details about the agents, mechanisms of action, and trial status",
  "footnotes": "MOA, mechanism of action; RBC, red blood cell; WT, wild type; mAb, monoclonal antibody; AML, acute myeloid leukemia; MDS, myelodysplastic syndrome; R/R, refractory/relapsed; MM, multiple myeloma; NHL, non-Hodgkin lymphoma."
}